METTL3 was shown to promote ovarian cancer cell proliferation, invasion, and migration through targeting pri-miRNA 126-5p, lncRNA RHPN1 antisense RNA 1 (head to head) (RHPN1-AS1) and AXL receptor tyrosine kinase (AXL) mRNA18,43,44. Here, AXL is linked to ovarian carcinoma.